Close Menu

NEW YORK (GenomeWeb) – Amgen and Syapse have agreed to collaborate in precision oncology, working together to develop observational research analytics tools to assess treatment outcomes and address "areas of unmet need" in cancer care, the companies said Wednesday.

Together, the companies will scan the Syapse Learning Health Network — a data-sharing network for precision oncology — to identify candidates for Amgen-sponsored clinical trials. They also will seek to extend such trials to community health centers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.